<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>38(1)</volume><submitter>Vivacqua G</submitter><funding>NIHR Cambridge Biomedical Research Centre</funding><journal>Movement disorders : official journal of the Movement Disorder Society</journal><pagination>153-155</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10092811</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Salivary α-Synuclein RT-QuIC Correlates with Disease Severity in de novo Parkinson's Disease.</pubmed_title><pmcid>PMC10092811</pmcid><pubmed_authors>Calo L</pubmed_authors><pubmed_authors>Belvisi D</pubmed_authors><pubmed_authors>Mason M</pubmed_authors><pubmed_authors>De Bartolo MI</pubmed_authors><pubmed_authors>Berardelli A</pubmed_authors><pubmed_authors>Fabbrini G</pubmed_authors><pubmed_authors>Wegrzynowicz M</pubmed_authors><pubmed_authors>Suppa A</pubmed_authors><pubmed_authors>Vivacqua G</pubmed_authors><pubmed_authors>Spillantini M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Salivary α-Synuclein RT-QuIC Correlates with Disease Severity in de novo Parkinson's Disease.</name><description/><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-05T11:29:51.596Z</modification><creation>2025-04-05T11:29:51.596Z</creation></dates><accession>S-EPMC10092811</accession><cross_references><pubmed>36259554</pubmed><doi>10.1002/mds.29246</doi></cross_references></HashMap>